Urs Regenass

2.4k total citations
43 papers, 1.3k citations indexed

About

Urs Regenass is a scholar working on Molecular Biology, Oncology and Biochemistry. According to data from OpenAlex, Urs Regenass has authored 43 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 14 papers in Oncology and 8 papers in Biochemistry. Recurrent topics in Urs Regenass's work include Polyamine Metabolism and Applications (9 papers), Amino Acid Enzymes and Metabolism (6 papers) and Nitric Oxide and Endothelin Effects (4 papers). Urs Regenass is often cited by papers focused on Polyamine Metabolism and Applications (9 papers), Amino Acid Enzymes and Metabolism (6 papers) and Nitric Oxide and Endothelin Effects (4 papers). Urs Regenass collaborates with scholars based in Switzerland, United States and Austria. Urs Regenass's co-authors include Helmut Mett, Thomas Meyer, Alex Matter, Carl W. Porter, Marcel Mueller, Peter Schneider, Peter Traxler, Jaroslav Staněk, Nicholas Lydon and François Lehembre and has published in prestigious journals such as Journal of Biological Chemistry, Development and Cancer Research.

In The Last Decade

Urs Regenass

42 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Urs Regenass Switzerland 23 860 315 223 194 145 43 1.3k
Jin-Keon Pai United States 19 1.5k 1.7× 385 1.2× 148 0.7× 148 0.8× 170 1.2× 31 2.1k
Sonia Lamontagne Canada 19 525 0.6× 191 0.6× 145 0.7× 314 1.6× 463 3.2× 22 1.3k
Ronald L. Merriman United States 17 767 0.9× 224 0.7× 50 0.2× 186 1.0× 89 0.6× 35 1.2k
James P. Thomas United States 17 781 0.9× 350 1.1× 101 0.5× 143 0.7× 57 0.4× 30 1.6k
Yohei Saito Japan 21 632 0.7× 214 0.7× 95 0.4× 228 1.2× 120 0.8× 82 1.2k
Alexander D. Lewis United Kingdom 19 855 1.0× 289 0.9× 148 0.7× 127 0.7× 31 0.2× 25 1.4k
Toshiya Tamura Japan 19 559 0.7× 233 0.7× 74 0.3× 154 0.8× 37 0.3× 53 969
Gabriel Pons Spain 23 1.3k 1.5× 427 1.4× 251 1.1× 47 0.2× 136 0.9× 60 2.1k
Loredana Vesci Italy 30 1.1k 1.3× 563 1.8× 74 0.3× 558 2.9× 144 1.0× 73 2.0k
Peppi Prasit United States 21 592 0.7× 126 0.4× 69 0.3× 242 1.2× 189 1.3× 44 1.2k

Countries citing papers authored by Urs Regenass

Since Specialization
Citations

This map shows the geographic impact of Urs Regenass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Urs Regenass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Urs Regenass more than expected).

Fields of papers citing papers by Urs Regenass

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Urs Regenass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Urs Regenass. The network helps show where Urs Regenass may publish in the future.

Co-authorship network of co-authors of Urs Regenass

This figure shows the co-authorship network connecting the top 25 collaborators of Urs Regenass. A scholar is included among the top collaborators of Urs Regenass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Urs Regenass. Urs Regenass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Ho Jeong, Masaki Hanibuchi, Sun-Jin Kim, et al.. (2016). Treatment of experimental human breast cancer and lung cancer brain metastases in mice by macitentan, a dual antagonist of endothelin receptors, combined with paclitaxel. Neuro-Oncology. 18(4). 486–496. 44 indexed citations
2.
Kim, Sun-Jin, Ho Jeong Lee, Hyun Jin Choi, et al.. (2015). Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice. Clinical Cancer Research. 21(20). 4630–4641. 50 indexed citations
3.
Kim, Sun-Jin, Seung Wook Kim, Seok Joong Yun, et al.. (2012). Antivascular Therapy for Multidrug-Resistant Ovarian Tumors by Macitentan, a Dual Endothelin Receptor Antagonist. Translational Oncology. 5(1). 39–47. 30 indexed citations
4.
Sundström, Lars, et al.. (2011). Antitumor Compound Testing in Glioblastoma Organotypic Brain Cultures. SLAS DISCOVERY. 16(8). 805–817. 14 indexed citations
5.
Colombi, Marco, Don Benjamin, Christiane Schaefer, et al.. (2010). Genome-wide shRNA screen reveals increased mitochondrial dependence upon mTORC2 addiction. Oncogene. 30(13). 1551–1565. 37 indexed citations
6.
Fogel‐Petrovic, Mirjana, Slavoljub Vujcic, Robert Häner, et al.. (1996). Sequence specific antisense oligonucleotide analog interference with spermidine/spermine N1-acetyltransferase gene expression.. PubMed. 16(5A). 2517–23. 4 indexed citations
7.
Fredenhagen, Andreas, Helmut Mett, Thomas Meyer, et al.. (1995). Protein Tyrosine Kinase and Protein Kinase C Inhibition by Fungal Anthraquinones Related to Emodin.. The Journal of Antibiotics. 48(11). 1355–1358. 27 indexed citations
8.
Kramer, Debora L., Helmut Mett, Amanda Evans, et al.. (1995). Stable Amplification of the S-Adenosylmethionine Decarboxylase Gene in Chinese Hamster Ovary Cells. Journal of Biological Chemistry. 270(5). 2124–2132. 45 indexed citations
9.
Kramer, Debora L., Jaroslav Staněk, Paula Diegelman, et al.. (1995). Use of 4-fluoro-l-ornithine to monitor metabolic flux through the polyamine biosynthetic pathway. Biochemical Pharmacology. 50(9). 1433–1443. 13 indexed citations
10.
Trinks, Uwe, Elisabeth Buchdunger, Pascal Furet, et al.. (1994). Dianilinophthalimides: Potent and Selective, ATP-Competitive Inhibitors of the EGF-Receptor Protein Tyrosine Kinase. Journal of Medicinal Chemistry. 37(7). 1015–1027. 74 indexed citations
11.
Hofer, Susanne, et al.. (1994). The protein kinase C inhibitor CGP 41251, a staurosporine derivative with antitumor activity, reverses multidrug resistance. International Journal of Cancer. 57(1). 104–110. 65 indexed citations
12.
Staněk, Jaroslav, Giorgio Caravatti, J Frei, et al.. (1993). 4-Amidinoindan-1-one 2'-amidinohydrazone: a new potent and selective inhibitor of S-adenosylmethionine decarboxylase. Journal of Medicinal Chemistry. 36(15). 2168–2171. 36 indexed citations
13.
Mett, Helmut, et al.. (1993). Pharmacological properties of the ornithine decarboxylase inhibitor 3-aminooxy-1-propanamine and several structural analogues. Cancer Chemotherapy and Pharmacology. 32(1). 39–45. 17 indexed citations
14.
Regenass, Urs, et al.. (1992). Differential inhibition of the epidermal growth factor-, platelet-derived growth factor-, and protein kinase C-mediated signal transduction pathways by the staurosporine derivative CGP 41251.. PubMed. 52(19). 5353–8. 58 indexed citations
15.
Erdelmeier, C., Urs Regenass, Topul Rali, & Otto Sticher. (1992). Indole Alkaloids within vitroAntiproliferative Activity from the Ammoniacal Extract ofNauclea orientalis1. Planta Medica. 58(1). 43–48. 43 indexed citations
16.
Regenass, Urs, Giorgio Caravatti, Helmut Mett, et al.. (1992). New S-adenosylmethionine decarboxylase inhibitors with potent antitumor activity.. PubMed. 52(17). 4712–8. 49 indexed citations
17.
Traxler, Peter, Johanna Geissler, W. G. Kump, et al.. (1991). Sulfonylbenzoyl-nitrostyrenes: Potential bisubstrate type inhibitors of the EGF-receptor tyrosine protein kinase. Journal of Medicinal Chemistry. 34(8). 2328–2337. 49 indexed citations
18.
Geleick, Detlef, Hansjakob Müller, Alex Matter, J. Torhorst, & Urs Regenass. (1990). Cytogenetics of breast cancer. Cancer Genetics and Cytogenetics. 46(2). 217–229. 53 indexed citations
19.
Curschellas, Enrico, Alex Matter, & Urs Regenass. (1987). Immunolocalization of cytoskeletal elements in human mammary epithelial cells. European Journal of Cancer and Clinical Oncology. 23(10). 1517–1527. 12 indexed citations
20.
Regenass, Urs & Hans Peter Bernhard. (1979). Rudimentary mutants ofDrosophila melanogaster. Development Genes and Evolution. 187(2). 167–177. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jin-Keon Pai Breakdown of academic impact, for papers by Sonia Lamontagne Breakdown of academic impact, for papers by Ronald L. Merriman Breakdown of academic impact, for papers by James P. Thomas Breakdown of academic impact, for papers by Yohei Saito Breakdown of academic impact, for papers by Alexander D. Lewis Breakdown of academic impact, for papers by Toshiya Tamura Breakdown of academic impact, for papers by Gabriel Pons Breakdown of academic impact, for papers by Loredana Vesci Breakdown of academic impact, for papers by Peppi Prasit
Rankless by CCL
2026